Category - News

Developments

EyePoint Pharma secures debt facility of up to $60-million

EyePoint Pharmaceuticals (NASDAQ:EYPT) has secured a debt facility of up to $60-million from CR Group, a healthcare-focused investment firm, to retire existing debt and provide additional working capital to support...

February 13, 2019

Developments

Eyenovia expands MicroProst Phase 3 patient population for IOP lowering

Eyenovia (NASDAQ:EYEN) is expanding the patient population for its Phase 3 MicroProst program for the lowering of intraocular pressure (IOP). Following discussions with the FDA, the study population will include...

February 13, 2019

Markets

BTIG starts Synlogic at buy; PT $22

BTIG launched coverage of Synlogic (NASDAQ:SYBX) with a “buy” rating and $22 price target. The stock closed at $9.56 on Feb. 12. “We view Synlogic’s approach to correct inborn errors of metabolism via addition of key...

February 13, 2019

Markets

BTIG starts Geron at buy; PT $4

BTIG launched coverage of Geron (NASDAQ:GERN) with a “buy” rating and $4 price target. The stock closed at $1.31 on Feb. 12. Geron is focused on development of imetelstat, a telomerase inhibitor active in the treatment...

February 13, 2019

Markets

HCW starts Inventiva at buy: PT €19

H.C. Wainwright initiated coverage of France-based Inventiva (PSE:IVA) with a “buy” rating and price target of €19. The stock closed at €6.40 on Feb. 12. Inventiva was spun out of Abbott Labs in 2012 and is focused on...

February 13, 2019

Markets

BTIG starts MEI Pharma at buy; PT $5.50

BTIG initiated coverage of MEI Pharma (NASDAQ:MEIP) with a “buy” rating and price target of $5.50. The stock closed at $2.96 on Feb. 12. “MEI Pharma is developing in-licensed drugs that we see as having good chances of...

February 13, 2019

Developments

MIT-led research team unveil oral insulin capsule for Type 2 diabetes

Researchers from the Massachusetts Institute of Technology, Brigham and Women’s Hospital and Novo Nordisk have come up with an oral insulin pill that could replace injections for patients with Type 2 diabetes, according...

February 11, 2019

Developments

IntelGenx to receive Japanese patent for RIZAPORT VersaFilm

IntelGenx (TSXV:IGX; OTCQX:IGXT) received a Decision to Grant notice from the Japanese Patent Office (JPO) for the VersaFilm formulation used in its thin oral film RIZAPORT product for the treatment of acute migraines...

February 11, 2019

Markets

Stifel starts Ra Pharma at buy; PT $55

Stifel initiated coverage of Ra Pharmaceuticals (NASDAQ:RARX) with a “buy” rating and $55 price target. The stock closed at $19.87 on Feb. 7. Ra Pharma uses a proprietary peptide chemistry platform to develop...

February 8, 2019

Markets

SVB Leerink cuts Solid Biosciences to MP; PT to $8 from $50

SVB Leerink downgraded Solid Biosciences (NASDAQ:SLDB) to “market perform” from “outperform” and slashed its price target to $8 from $50 after the company reported disappointing Phase 1/2 data from its experimental gene...

February 8, 2019

Category - News

Subscribe